TPR (TPR)

$29.7B
Market Cap
56.4
P/E Ratio
1.60
Beta
1.09%
Dividend Yield
Piotroski 7/9Altman Z 4.0 SafeBeneish M -3.02 CleanROIC−WACC -9.0%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 4.0 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics present a distinct divergence between profitability efficiency and capital allocation efficacy. While the DuPont decomposition reveals that earnings per share are driven primarily by high financial leverage (Equity Multiplier of 7.67x) rather than operational expansion or pricing power, this aggressive use of debt creates significant downside pressure given the negative ROIC-WACC spread of -9.0%. Despite these capital efficiency concerns, balance sheet strength and accounting integrity appear robust, evidenced by a Piotroski F-Score of 7/9, an Altman Z-Score of 4.0 indicating low bankruptcy risk, and a Beneish M-Score of -3.02 that suggests minimal earnings manipulation. The business model relies heavily on gross margins at 75.4%, yet the thin net margin of 2.6% leaves little room for error in cost management despite revenue growth moderating to just 5.1%.

Valuation metrics reflect substantial market optimism regarding future cash flow generation that is not currently supported by underlying returns or historical performance. The current P/E ratio of 56.4x stands at a significant premium relative to the implied fair value derived from DCF analysis, which prices in $73 per share based on specific growth and discount rate assumptions. This wide gap implies the market is pricing for sustained high-growth execution that contradicts the static ROIC profile; specifically, the valuation assumes future returns will materially improve upon the current -9% spread between capital invested and cost of capital without corresponding evidence in historical margin expansion or asset turnover acceleration.

Risk assessment highlights a notable discrepancy between institutional sentiment and insider positioning over the trailing 90-day period. While fundamental scores suggest operational stability, insiders have executed net selling totaling $25.4 million, potentially signaling skepticism about near-term execution risks or valuation levels. This insider activity contrasts with the high F-Score but aligns with the stretched multiple relative to intrinsic value models, creating a scenario where downside protection may rely on mean reversion in multiples rather than fundamental earnings acceleration.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.8%13.8%15.8%
2%$85$68$57
3%$93$73$60
4%$103$79$64

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.8%, terminal growth 3%. Fair value $73 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
4.0
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.02
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

75.4%
Gross Margin
2.6%
Net Margin
4.7%
ROIC
13.8%
WACC
ROIC − WACC Spread: -9.0%— Negative spread.
+5.1%
Revenue Growth (YoY)
-77.5%
Earnings Growth (YoY)
1.1B
Free Cash Flow
27%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

2.6%
Net Profit Margin
NI ÷ Revenue
×
1.07x
Asset Turnover
Revenue ÷ Assets
×
7.67x
Equity Multiplier
Assets ÷ Equity
=
21.4%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

6.67x
Debt / Equity
1.87x
Current Ratio
3.5x
Interest Coverage
2.4x
Net Debt / EBITDA
3.54%
FCF Yield
526.4M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$25M
Net Selling
0
Buy Transactions
8
Sale Transactions
2026-03-03DADLANI MANESHSold 5/8 qtrsSale$152,149
2026-02-18CREVOISERAT JOANNE CSold 2/8 qtrsSale$8M
2026-02-18CREVOISERAT JOANNE CSold 2/8 qtrsGrant$4M
2026-02-17GRECO THOMAS RSold 1/8 qtrsSale$2M
2026-02-17GRECO THOMAS RSold 1/8 qtrsGrant$650,852

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.88
Act: $1.03
+17.1%
Q3
✓ Beat
Est: $1.02
Act: $1.04
+2.1%
Q2
✓ Beat
Est: $1.27
Act: $1.38
+8.9%
Q1
✓ Beat
Est: $2.23
Act: $2.69
+20.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

20.1
Forward P/E
PEG Ratio
53.30
Price/Book
2M
Avg Volume
$161.97
52W High
$58.39
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$4.1B
Tracked Passive Exposure
8
ETFs Holding TPR
0.07%
Avg Weight in ETFs
$6.1T
Total ETF AUM

When investors buy or sell ETFs like VBR or XLY, the fund manager is mechanically forced to buy or sell TPR shares regardless of TPR's individual fundamentals. We estimate $4.1B of passive capital is structurally linked to TPR through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in TPR to visualize passive redemption contagion across ETFs and collateral stocks.

TPR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TPREpicenterVTIETFVOOETFIVVETFAMZNLow RiskAMZNLow RiskTSLALow RiskTSLALow RiskHDLow Risk
TPR Price Drop (%)0

If TPR (TPR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies AMAZON.COM INC (AMZN) as the most exposed collateral stock, sharing 1 ETFs with TPR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 29 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TPR Ownership Dynamics

Ticker
TPR

Float lock-up computed from 29 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TPR Capital Efficiency

How efficiently does TPR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.1B
EBITDA
$526M
FCF Conversion
208%
Reinvestment Rate
-108%
208% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.7%
ROIC − WACC Spread
-9.0%

TPR converts 208% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-9.0%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1391$131.73$11,987.43
2026-05-118,238$133.48$1.1M
2026-04-2088$155.85$13,714.8
2026-04-1640,933$151.37$6.2M
2026-04-153$150.87$452.61
2026-03-2520$144.02$2,880.4
2026-03-0957,715$144.15$8.3M
2026-03-05396$156.91$62,136.36
2026-03-0432,000$154.42$4.9M
2026-03-02402$155.47$62,498.94
2026-02-1766,158$153.80$10.2M
2026-02-133,610$152.66$551,102.6
2026-02-12596$154.67$92,183.32
2026-02-093,000$152.10$456,300
2026-02-056,443$129.92$837,074.56
2026-02-04398$127.03$50,557.94
2026-01-21730$129.16$94,286.8
2026-01-20136$130.69$17,773.84
2026-01-0810,900$130.97$1.4M
2025-12-223,832$125.42$480,609.44
2025-12-011,000$109.28$109,280
2025-11-26328$107.68$35,319.04
2025-11-24300$105.24$31,572
2025-11-21400$102.18$40,872
2025-11-1813,161$101.74$1.3M
2025-11-0722,610$98.81$2.2M
2025-11-051,530$106.39$162,776.7
2025-11-0422,182$106.33$2.4M
2025-10-22110$117.14$12,885.4
2025-10-2112,496$116.34$1.5M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare TPR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.